Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression and Transcriptome Profiling of Changes in a Cancer Cell Line Post-Exposure to Cadmium Telluride Quantum Dots: Possible Implications in Oncogenesis. | Dose Response | 2021 | 34177396 | PubTator, text mining | PubMed |
| SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis. | Neurol Genet | 2021 | 34169148 | PubTator, text mining | PubMed |
| Systematically Studying the Effect of Small Molecules Interacting with RNA in Cellular and Preclinical Models. | ACS Chem Biol | 2021 | 34166593 | PubTator, text mining | PubMed |
| Nusinersen in pediatric and adult patients with type III spinal muscular atrophy. | Ann Clin Transl Neurol | 2021 | 34165911 | PubTator, text mining | PubMed |
| Corrigendum: Case Report: Whole-Exome Sequencing With MLPA Revealed Variants in Two Genes in a Patient With Combined Manifestations of Spinal Muscular Atrophy and Duchenne Muscular Dystrophy. | Front Genet | 2021 | 34140971 | PubTator, text mining | PubMed |
| 2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia. | Front Pediatr | 2021 | 34136444 | PubTator, text mining | PubMed |
| Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity. | Curr Opin Chem Biol | 2021 | 34118759 | PubTator, text mining | PubMed |
| Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression. | J Cachexia Sarcopenia Muscle | 2021 | 34115448 | PubTator, text mining | PubMed |
| A Novel Minor Groove Binder as a Potential Therapeutic Agent for Myotonic Dystrophy Type 1. | ChemMedChem | 2021 | 34114350 | PubTator, text mining | PubMed |
| Guillain-Barré Syndrome With a Peculiar Course: A Case Report. | Cureus | 2021 | 34113515 | PubTator, text mining | PubMed |
| Argonaute binding within human nuclear RNA and its impact on alternative splicing. | RNA | 2021 | 34108230 | PubTator, text mining | PubMed |
| Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen. | Neuromuscul Disord | 2021 | 34099377 | PubTator, text mining | PubMed |
| Differential transcriptional and functional properties of regulatory T cells in HIV-infected individuals on antiretroviral therapy and long-term non-progressors. | Clin Transl Immunology | 2021 | 34094548 | PubTator, text mining | PubMed |
| Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA. | Front Neurol | 2021 | 34093395 | PubTator, text mining | PubMed |
| Emerging Oligonucleotide Therapeutics for Rare Neuromuscular Diseases. | J Neuromuscul Dis | 2021 | 34092651 | PubTator, text mining | PubMed |
| Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study. | Lancet Child Adolesc Health | 2021 | 34089650 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients. | Int J Mol Sci | 2021 | 34073630 | PubTator, text mining | PubMed |
| Metabolic Dysfunction in Spinal Muscular Atrophy. | Int J Mol Sci | 2021 | 34072857 | PubTator, text mining | PubMed |
| Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy. | Int J Neonatal Screen | 2021 | 34071063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=63